VERACYTE, INC.·4

Nov 21, 4:19 PM ET

Holstein Jens 4

4 · VERACYTE, INC. · Filed Nov 21, 2025

Insider Transaction Report

Form 4
Period: 2025-11-20
Transactions
  • Sale

    Common Stock

    2025-11-20$40.95/sh1,491$61,06035,708 total
  • Sale

    Common Stock

    2025-11-20$42.48/sh7,049$299,41728,659 total
  • Sale

    Common Stock

    2025-11-20$43.21/sh1,460$63,08627,199 total
Footnotes (4)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $40.86 to $41.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $41.89 to $42.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]Represents weighted average sales price. Sale prices for the transactions range from $43.075 to $43.37. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Documents

1 file
  • 4
    wk-form4_1763759939.xmlPrimary

    FORM 4